Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cells.
about
ICOS-ligand, expressed on human endothelial cells, costimulates Th1 and Th2 cytokine secretion by memory CD4+ T cellsCostimulatory pathways in transplantation.Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.Constitutive expression of the B7h ligand for inducible costimulator on naive B cells is extinguished after activation by distinct B cell receptor and interleukin 4 receptor-mediated pathways and can be rescued by CD40 signaling.TRAIL, caspases and maturation of normal and leukemic myeloid precursors.Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AML.TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways.Competition within the virus-specific CD4 T-cell pool limits the T follicular helper response after influenza infection.Pulmonary sarcoidosis is associated with high-level inducible co-stimulator (ICOS) expression on lung regulatory T cells--possible implications for the ICOS/ICOS-ligand axis in disease course and resolution.Allogeneic T cells induce rapid CD34+ cell differentiation into CD11c+CD86+ cells with direct and indirect antigen-presenting function.Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells.The emerging role of immune checkpoint based approaches in AML and MDS.Next generation immune-checkpoints for cancer therapy.
P2860
Q24296273-4B779F95-904A-48EB-B2D3-5436DE3A6BEFQ34187594-68FCE7EB-920A-4B92-AF06-C45EB048F568Q35166852-3A960554-F343-4466-9F05-3B645BBDBCC8Q36371140-385DD732-4543-46A5-8019-9DB805BD0B54Q36590964-2304A451-5FF5-45E5-8C61-B8CFBF672036Q38891877-D5637170-44CE-4E20-BB8B-7F41DBAF5083Q39644786-190C2B02-C4E3-43FE-B23D-7881C90B2F8CQ39832898-D3CD5A1A-3CE8-4C62-89FD-0432ECD72F64Q40976985-27A2EB5E-BC52-4C0C-827F-BFE745C47AABQ42741757-CD438A26-4BF1-46E1-86B6-3A285BC7D759Q44529294-D418B109-813D-4628-9F8D-2F7514CBAD61Q48173100-4AEF5795-1139-4DDC-8B8C-A5D26042DA14Q55383705-2425CF3E-5379-4064-A094-D9179B22E02E
P2860
Tumor necrosis factor-alpha regulates the expression of inducible costimulator receptor ligand on CD34(+) progenitor cells during differentiation into antigen presenting cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Tumor necrosis factor-alpha re ...... ulator receptor ligand on CD34
@nl
Tumor necrosis factor-alpha re ...... into antigen presenting cells.
@en
type
label
Tumor necrosis factor-alpha re ...... ulator receptor ligand on CD34
@nl
Tumor necrosis factor-alpha re ...... into antigen presenting cells.
@en
prefLabel
Tumor necrosis factor-alpha re ...... ulator receptor ligand on CD34
@nl
Tumor necrosis factor-alpha re ...... into antigen presenting cells.
@en
P2093
P2860
P356
P1476
Tumor necrosis factor-alpha re ...... into antigen presenting cells.
@en
P2093
Hayden-Ledbetter M
Ledbetter JA
Pezzutto A
Westermann J
P2860
P304
45686-45693
P356
10.1074/JBC.M108509200
P407
P577
2001-09-24T00:00:00Z